Search results - 6 results
Clinical Evolution and Disease Burden in Belgian Cystic Fibrosis Patients: effect of Newborn Screening?
diagnosis, clinical evolution and burden of therapy between NBS and clinically diagnosed CF patients. A standardized care program after CF- NBS is needed. Health Topics: Cystic fibrosis Cystische fibrose ...
Annual Report Belgian Cystic Fibrosis Registry 2018
Accession Number: D/2020/14.440/40 Keywords: annual report Cystic Fibrosis epidemiology mucoviscidose Abstract: SUMMARY This report presents the data collected in 2018. It is our hope that the analysis ...
Annual Report Belgian Cystic Fibrosis Registry 2017
Accession Number: D/2019/14.440/16 Keywords: annual report Cystic Fibrosis epidemiology mucoviscidose Abstract: This report presents the data collected in 2017. It is our hope that the analysis of the ...
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is a major complication in cystic fibrosis (CF) patients. Risk factors for ABPA and clinical deterioration in CF patients, negative for Pseudomonas ...
The burden of cystic fibrosis in Belgium: a registry-based study
Disability-Adjusted Life Years Mucoviscidosis Abstract: Background: Cystic fibrosis is the most common life-limiting autosomal recessive disease among people of European heritage. This rare disease is known to cause ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
associated with the primary outcome (Adjusted OR 2.45 95% CI 1.27-4.71 p=0.007). CONCLUSIONS: This is the first study to show that there is a protective effect from the use of CFTR modulator therapy and that ...